Table: begin end state 1 19 cytoplasmic 20 38 transmembrane 39 45 non-cytoplasmic 46 68 transmembrane 69 79 cytoplasmic 80 98 transmembrane 99 103 non-cytoplasmic 104 125 transmembrane 126 145 cytoplasmic 146 168 transmembrane 169 181 non-cytoplasmic 182 203 transmembrane 204 232 cytoplasmic 233 253 transmembrane 254 271 non-cytoplasmic 272 291 transmembrane 292 302 cytoplasmic 303 322 transmembrane 323 444 non-cytoplasmic 445 468 transmembrane 469 487 cytoplasmic 488 507 transmembrane 508 512 non-cytoplasmic 513 531 transmembrane 532 543 cytoplasmic
Input: >Ac3H11_3022 MSPEERKVIFASSLGTVFEWYDFYLYGSLAAIIAKQFFSGLDSGSAFIFALLAFAAGFIV RPFGAIFFGRLGDMIGRKYTFLVTILIMGLSTFIVGILPTYASIGVAAPIILIVLRLLQG LALGGEYGGAATYVAEHAPHGRRGAYTAWIQTTATLGLFLSLMVILGTRTIVGEEAFADW GWRVPFIVSIVLLAISVWIRLAMNESPAFQKMKAEGKTSKAPLKESFGEWKNLKIVILAL VGLTAGQAVVWYSGQFYALFFLTQALKVDGATANILVAVSLLIGTPFFIVFGSLSDKIGR KPIILAGCLLAALTYFPVFGALTKAANPALAEAQAKNKVVVVADANECSFQFNPTGTVKF TSSCDIAKQVLAGASVSYENAPGAAGTPAVIKIGETAITGYSSKGLPADEAKKKDGEFKK AVADALKAAGYPTKADPARIDKVMVTAILVYLVLLVTMVYGPIAAMLVEMFPTRIRYTSM SLPYHIGNGWFGGLLPTTAFAIVAQTGNMYNGLWYPIIIAAATVVIGGLFIKETKDVDIY AND
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server